Researchers are trying to unravel why some COVID-19 survivors suffer “brain fog” and other problems that can last for months, and new findings suggest some…
Obesity is linked to several cardiometabolic abnormalities, such as high blood sugar and hypertension, which are considered to be risk factors for Alzheimer’s disease. Nearly…
Riluzole, a drug that has been used for more than 20 years to slow the progression of ALS, commonly known as Lou Gehrig’s disease, was…
As the pandemic enters a new phase, and talk of getting ‘back to normal’ fades in the face of surging cases of COVID-19 and lagging…
Research presented today (Wednesday 28 July) at the 2021 Alzheimer’s Association International Conference (AAIC) in Colorado suggests transgender and non-binary adults are more likely to…
Alzheimer’s disease (AD), the most common type of dementia, causes the death of neurons and leads to shrinking of the brain. Patients with AD will…
Australians living with mild cognitive impairment (MCI) could know five years in advance whether they are at high risk of developing Alzheimer’s disease—the most common…
While efforts to develop Alzheimer’s medications have so far borne little fruit, new research highlights the therapeutic promise of two non-drug tools: light and sound.
Positive trends in global education access are expected to decrease dementia prevalence worldwide by 6.2 million cases by the year 2050. Meanwhile, anticipated trends in…
High levels of low-density lipoprotein (LDL) cholesterol in mid-life are associated with an increased risk of developing dementia and Alzheimer’s over a decade later, according…